Nachman Norwood & Parrott’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$2.12M Sell
8,693
-68
-0.8% -$16.7K 0.22% 86
2021
Q1
$2.18M Sell
8,761
-55
-0.6% -$13.1K 0.24% 84
2020
Q4
$2.03M Buy
8,816
+43
+0.5% +$9.91K 0.24% 82
2020
Q3
$2.23M Sell
8,773
-133
-1% -$32.9K 0.3% 72
2020
Q2
$2.1M Buy
8,906
+93
+1% +$21.2K 0.35% 68
2020
Q1
$1.79M Buy
8,813
+2,265
+35% +$495K 0.36% 65
2019
Q4
$1.58M Sell
6,548
-8
-0.1% -$1.76K 0.26% 76
2019
Q3
$1.27M Sell
6,556
-36
-0.5% -$6.91K 0.23% 83
2019
Q2
$1.22M Sell
6,592
-254
-4% -$45.5K 0.22% 85
2019
Q1
$1.3M Sell
6,846
-30
-0.4% -$5.73K 0.24% 80
2018
Q4
$1.34M Buy
+6,876
New +$1.34M 0.28% 77

Other funds holding AMGN

Nachman Norwood & Parrott's AMGN Position: Q2 2021 in Review

Nachman Norwood & Parrott reduced its Amgen (AMGN) stake by 0.78% in Q2 2021, selling an estimated $16.7K and leaving 8,693 shares worth $2.12M. The position accounts for 0.22% of the portfolio, ranked #86.

Nachman Norwood & Parrott first reported a position in AMGN in Q4 2018 and has held it in 11 quarters since. The position peaked at $2.23M in Q3 2020. 2,195 funds tracked by Wall St. Rank hold AMGN as of Q2 2021.

  • Nachman Norwood & Parrott held 8,693 shares of Amgen worth $2.12M as of Q2 2021.
  • Nachman Norwood & Parrott sold 68 Amgen shares in Q2 2021, an estimated $16.7K.
  • Amgen made up 0.22% of Nachman Norwood & Parrott's portfolio in Q2 2021, its #86 holding.
  • Nachman Norwood & Parrott first reported a position in Amgen in Q4 2018 and has held it in 11 quarters since.
  • Nachman Norwood & Parrott's Amgen position peaked at $2.23M in Q3 2020.
  • 2,195 funds tracked by Wall St. Rank held Amgen as of Q2 2021.

Based on Nachman Norwood & Parrott's 13F filing for Q2 2021, filed 13 Aug 2021.